Shanghai Allist Pharmaceuticals Statistics

Total Valuation

Shanghai Allist Pharmaceuticals has a market cap or net worth of CNY 25.44 billion. The enterprise value is 22.49 billion.

Market Cap	25.44B
Enterprise Value	22.49B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Sep 5, 2024

Share Statistics

Shanghai Allist Pharmaceuticals has 450.00 million shares outstanding. The number of shares has decreased by -1.09% in one year.

Shares Outstanding	450.00M
Shares Change (YoY)	-1.09%
Shares Change (QoQ)	-0.30%
Owned by Insiders (%)	11.39%
Owned by Institutions (%)	16.65%
Float	206.77M

Valuation Ratios

The trailing PE ratio is 23.23 and the forward PE ratio is 20.49.

PE Ratio	23.23
Forward PE	20.49
PS Ratio	8.91
PB Ratio	5.64
P/FCF Ratio	21.87
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.83, with an EV/FCF ratio of 19.33.

EV / Earnings	20.60
EV / Sales	7.90
EV / EBITDA	20.83
EV / EBIT	21.60
EV / FCF	19.33

Financial Position

The company has a current ratio of 7.97, with a Debt / Equity ratio of 0.00.

Current Ratio	7.97
Quick Ratio	7.77
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	0.00
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	2.73M
Profits Per Employee	1.05M
Employee Count	1,044
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +63.61% in the last 52 weeks. The beta is 0.55, so Shanghai Allist Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	+63.61%
50-Day Moving Average	49.18
200-Day Moving Average	50.08
Relative Strength Index (RSI)	61.57
Average Volume (20 Days)	5,842,410

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shanghai Allist Pharmaceuticals had revenue of CNY 2.85 billion and earned 1.09 billion in profits. Earnings per share was 2.43.

Revenue	2.85B
Gross Profit	2.70B
Operating Income	1.04B
Pretax Income	1.15B
Net Income	1.09B
EBITDA	1.08B
EBIT	1.04B
Earnings Per Share (EPS)	2.43

Full Income Statement

Balance Sheet

The company has 2.96 billion in cash and 1.31 million in debt, giving a net cash position of 2.95 billion or 6.56 per share.

Cash & Cash Equivalents	2.96B
Total Debt	1.31M
Net Cash	2.95B
Net Cash Per Share	6.56
Equity (Book Value)	4.51B
Book Value Per Share	10.03
Working Capital	2.95B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.22 billion and capital expenditures -56.01 million, giving a free cash flow of 1.16 billion.

Operating Cash Flow	1.22B
Capital Expenditures	-56.01M
Free Cash Flow	1.16B
FCF Per Share	2.59

Full Cash Flow Statement

Margins

Gross margin is 94.81%, with operating and profit margins of 36.58% and 38.37%.

Gross Margin	94.81%
Operating Margin	36.58%
Pretax Margin	40.37%
Profit Margin	38.37%
EBITDA Margin	37.86%
EBIT Margin	36.58%
FCF Margin	40.88%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.84%.

Dividend Per Share	0.50
Dividend Yield	0.84%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	16.49%
Buyback Yield	1.09%
Shareholder Yield	1.92%
Earnings Yield	4.30%
FCF Yield	4.57%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Shanghai Allist Pharmaceuticals has an Altman Z-Score of 27.5.

Altman Z-Score	27.5
Piotroski F-Score	n/a